These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 20653426)
1. Peptide mimicry of AICL inhibits cytolysis of NK cells by blocking NKp80-AICL recognition. Huang H; Zheng X; Tian Z; Sun R Immunol Invest; 2010; 39(6):587-97. PubMed ID: 20653426 [TBL] [Abstract][Full Text] [Related]
2. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Welte S; Kuttruff S; Waldhauer I; Steinle A Nat Immunol; 2006 Dec; 7(12):1334-42. PubMed ID: 17057721 [TBL] [Abstract][Full Text] [Related]
3. Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1. Akatsuka A; Ito M; Yamauchi C; Ochiai A; Yamamoto K; Matsumoto N Int Immunol; 2010 Sep; 22(9):783-90. PubMed ID: 20663776 [TBL] [Abstract][Full Text] [Related]
4. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses. Klimosch SN; Bartel Y; Wiemann S; Steinle A Blood; 2013 Oct; 122(14):2380-9. PubMed ID: 23929856 [TBL] [Abstract][Full Text] [Related]
5. Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80. Neuss S; Bartel Y; Born C; Weil S; Koch J; Behrends C; Hoffmeister M; Steinle A J Immunol; 2018 Aug; 201(4):1275-1286. PubMed ID: 29980609 [TBL] [Abstract][Full Text] [Related]
6. Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia. Deng G; Zheng X; Zhou J; Wei H; Tian Z; Sun R J Biol Chem; 2015 Sep; 290(37):22474-84. PubMed ID: 26198633 [TBL] [Abstract][Full Text] [Related]
7. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity. Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331 [TBL] [Abstract][Full Text] [Related]
8. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity. Rückrich T; Steinle A J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447 [TBL] [Abstract][Full Text] [Related]
9. NKp80 defines and stimulates a reactive subset of CD8 T cells. Kuttruff S; Koch S; Kelp A; Pawelec G; Rammensee HG; Steinle A Blood; 2009 Jan; 113(2):358-69. PubMed ID: 18922855 [TBL] [Abstract][Full Text] [Related]
10. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. Dennehy KM; Klimosch SN; Steinle A J Immunol; 2011 Jan; 186(2):657-61. PubMed ID: 21149606 [TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells. Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646 [TBL] [Abstract][Full Text] [Related]
12. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor. Lian RH; Freeman JD; Mager DL; Takei F J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224 [TBL] [Abstract][Full Text] [Related]
13. Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors. Drozdová A; Bojarová P; Křenek K; Weignerová L; Henssen B; Elling L; Christensen H; Jensen HH; Pelantová H; Kuzma M; Bezouška K; Krupová M; Adámek D; Slámová K; Křen V Carbohydr Res; 2011 Sep; 346(12):1599-609. PubMed ID: 21641586 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cell recognition of HLA class I molecules. Brooks AG; Boyington JC; Sun PD Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749 [TBL] [Abstract][Full Text] [Related]
16. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. Bolhuis RL; Roozemond RC; van de Griend RJ J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649 [TBL] [Abstract][Full Text] [Related]
17. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400 [TBL] [Abstract][Full Text] [Related]
18. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137 [TBL] [Abstract][Full Text] [Related]
19. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923 [TBL] [Abstract][Full Text] [Related]
20. NK cells can recognize different forms of class I MHC. Su RC; Kung SK; Gariépy J; Barber BH; Miller RG J Immunol; 1998 Jul; 161(2):755-66. PubMed ID: 9670952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]